ERGE vs. acidez después de la cirugía bariátrica: el daño silencioso que los pacientes pasan por alto

Introduction

For many patients who come into my office, the sleeve is not the right operation. And often, I can see that before I ever pick up a stapler. We continue to perform sleeves because they are fast, popular, and frequently requested by name. But if you already have reflux, a hiatal hernia, or a weak lower esophageal valve, a sleeve can create years of symptoms—and sometimes lead to a second operation.

The choice you make before surgery can determine whether you heal once or end up needing another procedure later. Here’s why I feel so strongly about this. Reflux after bariatric surgery is one of the most misunderstood problems in this field. Many patients think of it as heartburn—a nuisance that can be controlled with a pill.

But reflux is more than a symptom. It is a mechanical problem. Over time, uncontrolled acid exposure can damage the lining of the esophagus, cause a condition called Barrett’s esophagus, and, in the most serious cases, increase the risk of esophageal cancer. And here’s what makes reflux particularly concerning after a sleeve: some patients have significant reflux-related damage without feeling much at all.

They may have no burning. No obvious symptoms. But when we look inside the esophagus or measure acid exposure, the problem is already there. So this is not simply a video about heartburn.

It is about protecting your esophagus, choosing the right operation the first time, and understanding your options if reflux develops after surgery. We’ll cover why reflux happens, which operations can cause it, and which operations may improve it. We’ll also discuss how reflux is properly diagnosed and the treatment options available today—from medication and endoscopic procedures to anti-reflux repairs, magnetic devices, and conversion surgery.

By the end, you should understand what reflux after bariatric surgery can mean, what warning signs to take seriously, and what questions to ask your surgical team. Let’s get into it. Before we go any further, we need to clarify what we mean by “reflux.” People often use that word as if it means the same thing to everyone. It doesn’t. And that confusion explains why different doctors—and different studies—can report very different numbers.

For example, ask ten studies how many patients develop reflux after a sleeve, and you may see estimates below 10% in some studies and above 50% in others. Same operation. Very different answers. Why? Because they may not be measuring the same thing.

One study may ask patients, “Do you have heartburn?” Another may count how many patients are taking reflux medication. Another may use a camera to look for inflammation in the esophagus. And another may place a small probe to measure acid exposure over an entire day.

Those are four different ways of defining reflux. So, when someone gives you a percentage, ask one question:

How was reflux measured?

Now let’s define the terms. There is ordinary acid reflux. That means stomach contents, including acid, move upward and irritate the esophagus. There is de novo reflux. “De novo” means new. You did not have reflux before surgery, and now you do.

There is persistent or worsening reflux. You had reflux before surgery, and it continued or became more severe afterward. And then there is bile reflux. This is different from acid reflux. Bile is digestive fluid that can move upward from farther down the digestive tract. Standard acid-blocking medications may not correct the underlying problem, so it requires a different evaluation and treatment approach.

Now for the part that concerns me most:

Many people assume that if they do not feel reflux, they do not have it. That is not always true. After a sleeve, some patients have significant acid exposure or inflammation in the esophagus without typical heartburn. They may have few symptoms—or none at all.

If we only look for symptoms, we can miss the disease until it has already caused damage. That is why objective testing matters. The Lyon Consensus provides a framework for diagnosing reflux using measurable evidence—not symptoms alone. That evidence may include inflammation seen on endoscopy or abnormal acid exposure measured over time.

For the rest of this discussion, when I use the word “reflux,” I am not talking about occasional heartburn after a large or spicy meal. I am talking about measurable reflux disease—the kind that can injure the esophagus, whether you feel it or not. That distinction matters. It changes how reflux is diagnosed, how it is treated, and how we decide whether a sleeve is the right operation in the first place.

Which Operation Causes Reflux, and Which One Fixes It

Now let’s go operation by operation, because this can directly affect your decision. I’ll start with the sleeve. It’s the most common operation, and it’s the one patients ask me about most often. Over the long term, roughly 20% to 30% of sleeve patients develop significant reflux. Some had reflux before surgery. Many did not. When reflux starts after surgery, we call it de novo reflux. In other words, it is new.

And reflux does not stop at heartburn. Over time, the lining of the esophagus can become inflamed. In some patients, it changes into a condition called Barrett’s esophagus. Barrett’s is a precancerous change.

That is why we take reflux seriously. It is not just discomfort. Over time, it can lead to more serious problems. Now let’s compare the sleeve with gastric bypass. We have a strong study that looked at this directly. It was a randomized trial, which is one of the strongest types of medical evidence.

The researchers assigned similar patients to either a sleeve or a bypass. They did more than ask how the patients felt. They looked inside the esophagus and measured acid exposure.

Here is what they found:

• New inflammation of the esophagus occurred in 47% of sleeve patients, compared with 9% of bypass patients.
• Measurable acid reflux occurred in 49% of sleeve patients, compared with 16% of bypass patients.

Let that sink in. Roughly half of the sleeve patients had measurable acid reflux. The bypass patients did much better. In many cases, bypass also improved reflux that was already present before surgery.

Now, I want to give you the full picture. Another large real-world study reached a different conclusion. It followed a very large number of patients and suggested that, over the long term, sleeve patients did not necessarily have worse reflux outcomes. They also had fewer hospital readmissions.

So this remains a genuine debate in bariatric surgery. The evidence is not perfectly consistent. But when I put the carefully measured data together with what I see in my own patients, I lean strongly toward the findings from the randomized trial: the sleeve carries more reflux risk than gastric bypass. Now let’s talk about the one-anastomosis gastric bypass, also called the mini bypass or OAGB.

Compared with the OAGB, the sleeve again appears to have more reflux—roughly three to four times more overall reflux, and about four times more new reflux. But the OAGB has an important trade-off. It can cause bile reflux. Remember, bile reflux is different from acid reflux. It involves digestive fluid coming back up from lower in the digestive tract.

So the OAGB may reduce acid reflux, but it can create a different problem. That is something we watch for closely. Then there is the standard gastric bypass, the Roux-en-Y gastric bypass. This is generally the operation associated with the lowest reflux risk. If reflux is your main concern, it is often the preferred option.

But bypass is not a permanent guarantee. Years later, a small number of patients can develop reflux or swallowing problems. Sometimes the esophagus becomes less effective at moving food downward. That situation is uncommon, but it is real.

And briefly, what about the other procedures? The old adjustable gastric band was notorious for causing reflux and swallowing problems. That is one reason it is rarely used today. The larger malabsorptive operations, such as the duodenal switch and SADI, are built around a sleeve. They can therefore carry some of the same reflux risk. However, the long-term data for these procedures are less complete.

So here is the main point:

The gastric bypass generally offers the most protection against acid reflux. The sleeve can increase reflux risk. And the mini bypass may trade acid reflux for bile reflux.

Keep that distinction in mind, because it affects everything that comes next.

Why It Happens: The Plumbing Behind the Problem

Now you know which operation is more likely to cause reflux and which one usually helps fix it. Let’s talk about why. Once you understand the mechanics, the whole issue becomes much easier to understand.

Here is the first thing many people get wrong:

Reflux is not simply a problem of having too much acid. It is usually a problem with the valve that is supposed to keep stomach contents down.

At the top of your stomach, where it connects to your esophagus, there is a natural one-way barrier. Part of that barrier is a muscle. Part of it comes from the shape of the connection—a sharp angle where the esophagus meets the stomach. We call that the angle of His.

Together, these structures help keep stomach contents where they belong. Now consider what happens with a sleeve. During a sleeve gastrectomy, the outer curve of the stomach is removed. A large, stretchy pouch becomes a narrow tube.

And a narrow tube is a high-pressure system. Think about squeezing a tube of toothpaste. As the pressure rises inside, the contents are pushed upward toward the valve.

The shape at the top also changes. That sharp angle becomes flatter. So now there are two problems:

• More pressure pushing upward from below.
• A weaker barrier trying to hold everything back.

That is how reflux develops. The sleeve also does not stretch and relax the way a normal stomach does. A normal stomach expands to accommodate a meal. A sleeve is narrower and less flexible, so the pressure can rise quickly after eating.

In some patients, the sleeve also empties more slowly. Food and acid remain in the stomach longer, with more opportunity to move upward. There are also several mechanical problems I look for when a patient develops significant reflux after surgery.

The first is a hiatal hernia. This happens when the upper part of the stomach moves up through the diaphragm into the chest. If a hiatal hernia was present before surgery and was not repaired, the sleeve can make the problem worse. The second is the sleeve moving upward into the chest.

The third is a twist or kink in the sleeve. The fourth is a narrowing, often in the middle of the sleeve, that causes food and fluid to back up—almost like a clog in a pipe. The fifth is leaving too much stomach at the top of the sleeve. That area can act like a small reservoir where acid collects.

These are all mechanical problems. And that matters because each one may require a different solution. When someone develops reflux after a sleeve, the first step is to find the actual cause. You cannot choose the right treatment until you know what is happening.

Now let’s talk about what chronic reflux can do over time. When acid repeatedly washes up into the esophagus, it can cause ongoing injury. The muscles of the esophagus—the muscles that help push food downward—may become weaker and less effective. As the esophagus clears acid less efficiently, the acid remains there longer. That causes more irritation, which can further impair the esophagus.

It becomes a cycle. That is why we do not simply ignore persistent reflux. The longer it continues, the more difficult it may be to reverse the damage. Now for the good news: gastric bypass addresses several of these problems at the same time.

With a Roux-en-Y gastric bypass, the new stomach pouch is small, and most of the stomach is taken out of the food pathway. That means less acid is present near the esophagus. Bile is also routed away from the pouch, which reduces the chance of it moving upward. The pouch usually empties efficiently, so food and fluid are less likely to sit there and build pressure.

And as weight decreases, the pressure within the abdomen often decreases as well. That can reduce stress on the reflux barrier. Together, these changes explain why gastric bypass is commonly used when reflux is a major concern. The one-anastomosis gastric bypass, or OAGB—sometimes called the mini bypass—also moves most acid away from the esophagus. But it has a different concern.

Because of the way the intestine is connected, bile can move back into the pouch. That creates bile reflux. It is a different fluid, a different problem, and it requires a different approach.

So here is the main idea:

Reflux after bariatric surgery is a mechanical problem. It involves pressure, valves, anatomy, and the direction in which acid and bile move. When we talk about choosing the right operation for the right patient, that is what we mean. The decision is based on how the anatomy is likely to function—not simply on personal preference or the name of the operation.

How Reflux Actually Shows Up, and Where It Goes

Let’s talk about what reflux actually feels like—because it does not always look the way you expect. Most people think of heartburn: a burning feeling in the middle of the chest, often after a meal and worse when lying down. That is the classic symptom, and many patients experience it.

The second major symptom is regurgitation. Food or sour liquid comes back up into your throat or mouth. Some patients wake up coughing, with a bitter taste, or with a wet pillow. That can happen when reflux reaches the throat during sleep.

The third symptom is trouble swallowing. Food feels stuck. It moves down slowly. Sometimes swallowing hurts. We call this dysphagia.

Dysphagia always gets my attention. It can mean more than acid reflux. It may point to narrowing, twisting, or another mechanical problem. Here is where reflux surprises many people: it does not always stay in the chest.

It can cause a cough that will not go away. A hoarse voice. Constant throat-clearing. A sore throat every morning.

Some patients see a lung specialist or an ear, nose, and throat specialist. They are treated for asthma or allergies, but nothing really helps. In some cases, reflux is reaching the throat or airway, especially at night. These are called extra-esophageal symptoms—symptoms outside the esophagus.

In more serious cases, reflux can be aspirated into the lungs.

But I want to return to the most important point from the beginning:

You can have significant reflux damage and feel nothing.

That is silent reflux. Some patients after sleeve surgery have clear inflammation, abnormal acid testing, and no symptoms at all. No heartburn. No pain. They feel completely fine.

If we rely only on symptoms, we may not discover the problem until the damage is already advanced. That is why, after a sleeve, I do not rely on symptoms alone when deciding whether evaluation is needed. Timing also matters. Some patients develop reflux within the first few weeks after surgery. Early on, swelling, temporary narrowing during healing, orpre-existing reflux that has become worse may be contributing.

But the reflux I watch closely is the reflux that appears later—one year, two years, or even five years after surgery. These patients may have felt excellent for a long time. Then heartburn slowly begins to creep in. This is called de novo reflux: new reflux that develops after surgery. It often builds gradually instead of appearing all at once.

From there, reflux can follow one of three paths.

The first path is improvement. Early reflux caused by swelling may settle as healing progresses. Weight loss can also reduce pressure on the valve, so some patients improve over time.

The second path is persistence. Reflux continues and becomes something you manage every day with medication. It does not fully go away on its own.

The third path is progression. Reflux continues. The esophagus remains exposed to it. Irritation can progress to inflammation and, over time, to Barrett’s esophagus—precancerous changes in the lining.

The difficult part is that, early on, you cannot always tell which path you are on by how you feel. A patient whose reflux is progressing may feel perfectly well for years. That is the central problem. This is why I do not treat reflux after surgery as a nuisance to simply wait out. I treat it as a condition we need to look for, measure, and stay ahead of.

The patients who do best are usually the ones we identify early—before they ever develop the most serious symptoms.

What Reflux Does If You Leave It Alone

I need to get serious with you for a few minutes. I don’t ignore reflux because it’s a nuisance. I take it seriously because when acid keeps coming up, it damages your body in predictable steps. Let’s walk up that ladder, one rung at a time.

The first rung is inflammation—esophagitis. Think of it like a rug burn on the inside of your food pipe. It’s raw, red, and irritated. After a sleeve, this is very common. In long-term studies, nearly three out of four sleeve patients showed some degree of this inflammation. That is a majority of patients.

The second rung is a stricture, or narrowing. Sometimes this comes from that chronic irritation and scarring. Sometimes it’s from the sleeve itself being too tight or twisted. Either way, food starts to get stuck. Swallowing becomes difficult. This happens in roughly one to three percent of sleeve patients. The good news? We can usually fix this by stretching the area open with a camera scope. That works most of the time. When it doesn't, we may need surgery.

The third rung is what I care about most: Barrett’s esophagus.

Let me explain this in plain language. When your esophagus gets burned by acid over and over for years, your body tries to protect itself. It swaps out the normal lining for a tougher, more durable kind of tissue—the kind found in your intestine. That sounds clever, but it’s not. That new tissue is unstable. It’s a precancerous change—the first step on the road to esophageal cancer.

Here is the number that should get your attention: in long-term sleeve studies, Barrett’s appeared in six to sixteen percent of patients. In the general population, that number is closer to one or two percent. The sleeve increases that risk. And remember: many of these patients felt completely fine. No heartburn. Nothing.

I am not telling you this to scare you away from surgery. Iam telling you this so you understand why we watch you so closely. Barrett’s is slow. The jump from Barrett’s to cancer is rare—well under one percent per year. If we are doing our surveillance, we catch these changes early, long before they become dangerous. That is the entire point. We stay ahead of the damage.

Let me connect this to your choice of operation. Chronic, erosive reflux is the single biggest known risk factor for this type of esophageal cancer. When I choose an operation that causes reflux, I’m not just signing you up for heartburn; I am potentially starting you on that ladder. When I choose the bypass, I am keeping you off it.

A quick word on the medication—the "prazoles," or PPIs. They work. They calm the symptoms. But here is what the sleeve data shows: once patients start these pills after a sleeve, they mostly stay on them. In national studies, PPI use after a sleeve is seven times higher than after a bypass. It often becomes a pill every day for the rest of your life.

I want to be honest about the trap: the pill treats the burn. It quiets the acid. But it does not fix the broken valve, and it may not fully protect you against bile or other non-acid reflux. A patient can feel fine on medication and still be quietly climbing that ladder. Feeling better is not the same as being safe.

Inflammation. Narrowing. Barrett’s. A lifetime of pills that mask more than they cure. That is what reflux does when you leave it alone. That is exactly why, next, we are going to talk about how we look for it, measure it, and stay ahead of it. You cannot fix what you have not found.

How We Actually Find It and Measure It

A patient comes to me with reflux after a sleeve. Or maybe they feel fine but are due for surveillance. Either way, this is how I evaluate them. This is the part that separates guessing from knowing.

The first rule in my office is simple:

Symptoms are not a diagnosis.

How you feel does not always tell me what is happening inside. Some people have severe burning, yet their esophagus looks normal. Others feel nothing, but testing shows significant reflux and tissue damage. So I do not rely on symptoms alone. I look, and I measure.

The first and most important tool is an endoscopy, also called an EGD. I pass a thin camera through your mouth and examine the esophagus. I look for redness, irritation, erosions, narrowing, and other signs of injury. I also examine the valve at the top of the stomach. I look at how well it closes and check for a hiatal hernia. Then I look at the sleeve itself.

Is the sleeve straight? Has it twisted? Is there a narrowed area? Is there a portion of the stomach that was left too large?

While I am there, I may take biopsies. These are tiny tissue samples. Barrett’s esophagus, the precancerous change we discussed earlier, may not be obvious just by looking. A pathologist often needs to examine the tissue under a microscope.

For patients who have had a sleeve, I do not necessarily wait for symptoms before recommending an endoscopy. Because silent reflux and Barrett’s can occur without heartburn, surveillance may be appropriate even when you feel well. The second tool is a swallow study, usually called a barium swallow or an upper GI study. You drink a liquid that shows up on X-rays. We then watch it move through your esophagus and sleeve in real time.

This test gives me information about movement and shape. Is there a hiatal hernia? Has part of the sleeve moved up into the chest? Is there a twist or kink? Is the sleeve emptying normally, or is material backing up?

The scope shows me the lining. The swallow study shows me the plumbing. Together, they give me a much more complete picture. Sometimes I need to prove how much reflux is happening, not just look for the damage it may have caused. That is where reflux monitoring comes in.

A pH study measures acid directly. A small sensor records how often acid enters the lower esophagus and how long it stays there. Depending on the test, monitoring may continue for one to four days. At the end, I can see how much acid exposure occurred, how often it happened, whether it was worse during the day or at night, and whether the episodes matched the symptoms you reported.

There are two common ways to perform this test. One uses a small wireless capsule placed during endoscopy. Most patients barely notice it, and it can record for several days. The other uses a thin catheter that passes through the nose and stays in place for about a day.

Now, in some patients—especially after certain bypass procedures—I also need to look for non-acid reflux. Remember, bile is not acid. A standard pH test may not detect it. The result can look normal even though reflux is still occurring.

That is where impedance testing helps. It can detect acid and non-acid material moving up into the esophagus, including reflux that a standard pH test might miss. The fourth tool is a muscle test called manometry. We pass a soft catheter through the nose and measure how strongly the esophagus contracts. We also evaluate how the valves open and close.

Manometry does not diagnose reflux by itself. It answers different questions. First, before I perform an anti-reflux operation, I need to know whether the esophagus can push food downward effectively. If the esophagus is already weak, tightening the area could trade reflux for difficulty swallowing. That is not a good trade.

Second, manometry can identify a motility disorder that looks like reflux but is actually a problem with the esophageal muscles. Those conditions require different treatments.

So here is how I think about the entire toolbox:

• Endoscopy shows me the tissue and allows me to look for Barrett’s.
• A swallow study shows me the anatomy and how things move through it.
• Reflux monitoring measures acid and, when needed, non-acid reflux.
• Manometry tells me whether the esophagus is strong enough for a particular treatment.

I do not need every test for every patient. For routine surveillance, an endoscopy may be enough. But if you have significant symptoms and we are considering another operation, I want the complete picture before making a decision. The goal is to match the treatment to the cause.

And we cannot do that until we know what the cause is.

Picking the Right Operation Before the First Cut

This is where I can make the biggest difference in your future. The best time to address reflux is before surgery—before I ever make the first incision. The most powerful decision is choosing the right operation for the right patient. Get that decision right, and we may prevent years of reflux problems. Get it wrong, and we may spend years trying to correct them.

So what do I look at before surgery?

The strongest predictor of reflux after a sleeve is often the simplest one:

Do you already have reflux?

If you do, a sleeve may make it worse. Studies have found that patients with reflux before surgery are more than three times as likely to have reflux after a sleeve. So if you are already having heartburn every night, the sleeve may be working against you from the beginning. But there is an important complication: many people have reflux without feeling it.

That is silent reflux. I cannot rely only on your symptoms. I need to evaluate what is happening inside. That is one reason an endoscopy before surgery can be so important.

During the endoscopy, I pay close attention to the valve at the top of the stomach. We can grade its appearance from one to four using the Hill classification. A grade-one valve is tight and closes well around the endoscope. A grade-four valve is wide open.

The worse the valve looks before surgery, the greater the concern that a sleeve may lead to reflux afterward. Some studies have found a dramatic increase in risk as the grade rises. In one study, every patient with a grade-four valve developed reflux and inflammation. There are also newer grading systems, including one developed by the American Foregut Society, that examine the valve in greater detail.

The basic principle remains the same:

The weaker the valve looks before surgery, the more carefully we need to consider the operation.

Now let’s talk about hiatal hernias. A hiatal hernia occurs when the upper part of the stomach moves up through the diaphragm. It can contribute to reflux, but it is not the entire story. The research is mixed. Some studies show that a hiatal hernia increases the risk of reflux. Other carefully designed studies have not found a clear relationship between the hernia itself and acid-related damage.

Even repairing the hernia during a sleeve has not consistently eliminated reflux in every study. So a hiatal hernia matters, but it is only one piece of the puzzle.

We also consider other risk factors, including:

• Higher BMI
• Diabetes
• Pre-existing reflux
• Hiatal hernia
• High triglyceride levels

Researchers have used these factors to build risk scores and prediction tools. These tools are not perfect, but they can help estimate risk more accurately than a guess. Here is how I use all of that information in practice. If you have significant reflux before surgery, a loose grade-three or grade-four valve, or a high predicted risk, I want to have a direct conversation with you about the options.

In many of these situations, I will recommend considering gastric bypass rather than a sleeve. Why? Because the bypass is generally the bariatric operation most often used to treat significant reflux. If someone is already at high risk, choosing the operation most likely to worsen reflux may not make sense.

Professional guidance also supports bypass as the preferred option for patients with severe reflux or severe esophageal inflammation. But I want to be fair. The evidence is not perfectly uniform. Some large studies have suggested that the long-term differences may be less dramatic than earlier research indicated. Those studies have also reported differences in later hospital admissions.

So this is not completely black and white. Any surgeon who presents it that way is oversimplifying the decision. But when I am looking at a specific patient with a weak valve, significant esophageal inflammation, and nightly heartburn, I am not going to ignore those warning signs. I am going to choose the option that best protects that patient’s esophagus.

Here is the practical takeaway:

Before surgery, you should have a careful evaluation—not just a quick conversation about symptoms. That may include an endoscopy, an assessment of the valve, and an honest discussion about both obvious and silent reflux. The decision made before surgery may affect your health for the next twenty years. The right operation is not simply the one you prefer.

It is the one that best fits your anatomy, your reflux risk, and your long-term health.

Building the Sleeve So It Doesn’t Reflux

Let’s say we decide the sleeve is still the right operation for you. My job is to build it in a way that gives you the best chance of avoiding reflux. Because a sleeve is not just a sleeve. The choices made during surgery can affect your reflux risk for years.

Here is how I think about those choices in the operating room.

First: the hiatal hernia.

If I find a hiatal hernia—a weakness in the diaphragm that allows the stomach to slide upward—I repair it during the same operation. The data supports that approach. When surgeons repair the hernia at the time of the sleeve, reflux is more likely to go into remission. In pooled studies, patients were about three times more likely to see their reflux resolve when the hernia was repaired.

And in a five-year study that included follow-up scopes, patients who had their hernia repaired had much less inflammation in the esophagus than patients whose hernia was left alone. So if there is a hernia, I repair it. That is not optional in my practice. But I also want to be clear about the limits. Repairing the hernia helps the reflux you already have. It does not completely prevent new reflux from developing after surgery.

Studies show that hernia repair does not reliably reduce the rate of de novo reflux—the kind that appears for the first time after the sleeve. It is an important tool, but it is not a magic shield.

Second: the angle at the top of the stomach.

There is a natural angle where the esophagus meets the stomach. We call it the angle of His. It is part of your anti-reflux barrier. You can think of it as a small flap valve.

A sleeve can flatten that angle and make reflux more likely. So another option is to rebuild it—to recreate that sharper angle. The early data is encouraging. In one study, patients who had the angle reconstructed had reflux symptoms about 14% of the time, compared with 46% after a standard sleeve.

Other studies have shown the same pattern continuing for up to two years. Protecting and rebuilding that angle is one of the most promising ways to reduce reflux during sleeve surgery.

Third: how wide I make the sleeve.

We size the sleeve over a tube called a bougie. It might seem logical that tighter is better: a smaller stomach should mean more weight loss. But there is a trade-off. A tighter sleeve creates higher pressure. And higher pressure can push acid upward.

The data shows this clearly. Smaller bougies—around 32 to 36—may produce slightly more weight loss, but they are also linked to more reflux and more narrowing, or strictures. In pooled studies, the narrowest sleeves had almost twice the reflux risk.

So I do not aim for the tightest sleeve possible. I generally aim for a middle range, around 36 to 40. That can provide strong weight loss without creating excessive pressure and increasing your reflux risk.

Fourth: how much of the bottom of the stomach I preserve.

The lower part of the stomach is called the antrum. It acts like a pump. It helps push food forward and keeps the sleeve draining. If I cut too close to the outlet and remove too much of that pump, the sleeve may not empty as well. Food can sit there. Pressure can build. And that pressure can contribute to reflux.

So I preserve the antrum. I start the staple line a reasonable distance from the outlet rather than cutting right up against it. The data supports this approach. Preserving the antrum appears to protect against reflux and prolonged vomiting, especially during the first several months.

There is a real trade-off with weight loss. But I am not going to remove so much of the pump that you are left with a sleeve that does not drain properly.

And fifth: protect the top, and do not over-resect.

A careful mechanical study described the problem in simple terms. Reflux after a sleeve can result from two things:

• Damaging the structure where the esophagus meets the stomach
• Removing too much stomach and creating excessive pressure

The recommendation was straightforward: stay away from the cardia, the very top of the stomach, and do not remove more than about three-quarters of the stomach. So I protect the top, and I do not get overly aggressive at the bottom. Some surgeons go a step further and add a wrap. They combine the sleeve with a fundoplication, wrapping part of the stomach around the lower esophagus to create an additional anti-reflux barrier.

The reflux results can be excellent—sometimes better than hernia repair alone. But there is an important trade-off. The procedure can lead to more complications and a higher rate of reoperation. So it is a tool. It may be useful in selected patients, but it is not free of risk.

Here is the main point:

When you hear, “I’m getting a sleeve,” understand that many decisions are hidden inside that phrase. The hernia repair. The angle at the top. The bougie size.

The antrum. How much stomach is removed. Each one is a lever. Pulling those levers in the right direction is how we build a sleeve that moves food forward without creating unnecessary pressure and reflux.

Ask your surgeon how they build the sleeve. You have every right to know.

The First Things We Try, and They Work More Often Than You Think

So you have reflux after surgery. We have evaluated you, performed the appropriate testing, and figured out what is happening. Now what do we do about it? Here is the good news: for most people, we start with the simple options. And they work more often than you might expect.

Surgery is a real treatment for reflux, and we will get to it. But it is not where we begin. It is where we end up when simpler treatments fail or when there is a mechanical problem that medication cannot fix. Let’s go up the ladder one step at a time.

First: lifestyle.

I know. Many people roll their eyes when a doctor says “lifestyle.” But in this case, it matters, and the evidence is strong. Weight loss helps reflux. It is one of the best-supported treatments we have. If you still have weight to lose, losing that weight may reduce your reflux on its own.

Then there are the smaller changes:

• Do not eat within three hours of lying down.
• Raise the head of your bed a few inches.
• Cut back on alcohol, smoking, caffeine, and chocolate.
• Avoid large, heavy, greasy meals.
• After a sleeve, do not overfill your stomach. A full sleeve is a high-pressure sleeve, and that pressure can push acid upward.

One study found that women who combined several healthy habits—maintaining a healthy weight, not smoking, exercising, and limiting coffee—had about half the reflux of women who did none of those things. That is a meaningful reduction from habits alone.

Second: the acid blocker, or PPI.

These include medicines such as omeprazole and pantoprazole. They reduce the amount of acid your stomach produces and are the workhorses of reflux treatment. For a patient with reflux after a sleeve who has addressed weight and lifestyle factors and has no mechanical problem, a PPI is usually the first medication we try. For many people, it controls the symptoms.

Take it correctly. The usual guidance is to take it 30 to 60 minutes before a meal—not at bedtime. Timing matters because the medicine works better that way. There are two important cautions.

First, if you had a gastric bypass—either a mini-bypass or a Roux-en-Y bypass—we often keep you on a PPI intentionally to help protect against ulcers at the surgical connection. That is standard practice. It may be prescribed for at least 90 days and sometimes longer, especially if you smoke. Second, PPIs are useful medications, but they are not harmless candy.

Long-term, high-dose use can affect levels of magnesium and vitamin B12. Those are nutrients you already need to monitor closely after bariatric surgery. So we use the lowest dose that controls your symptoms and continue checking your nutritional levels. More is not automatically better.

Here is another honest point about the sleeve: sleeve patients are more likely than bypass patients to remain on acid-blocking medication long term. One nationwide study followed patients for years and found that sleeve patients had about a seven-times-higher chance of remaining on long-term acid blockers. So a PPI can help. But for some sleeve patients, it becomes a medication they never manage to stop.

That may be one reason to start discussing a more definitive treatment.

Now, step two and a half: what if the acid blocker does not work?

Before moving to surgery, I ask one question:

Is this actually acid? Remember that bypass patients can have bile reflux. If bile is coming upward rather than acid, an acid blocker is the wrong tool. You can increase the PPI, but it may not help because acid is not the main problem.

When the medication fails, that is often the signal to determine what type of reflux is occurring. If testing shows bile reflux, we use a different group of treatments. One option is ursodiol, also called ursodeoxycholic acid. It is a gentler bile acid that can displace more irritating bile and allow the lining to heal.

In bypass patients with bile-related pain and gastritis, ursodiol has helped when an acid blocker alone did not. In one series, about 80% of patients improved. There are other options as well.

Sucralfate acts like a liquid bandage, coating and protecting the irritated lining.

Cholestyramine can bind bile, although the evidence for it is limited.

In more difficult cases, baclofen may reduce the number of times the valve opens and allows reflux to come upward. It can help with non-acid reflux, but it may cause drowsiness and dizziness, so it is not usually the first choice.

So the treatment ladder is straightforward:

Start with weight loss and lifestyle changes. Add an acid blocker and take it correctly. If it does not work, determine whether the reflux is acid or bile, because bile requires a different approach. Most people do not need to go beyond this point. They improve with simple treatment and remain stable.

But some people do everything correctly, take the medication as directed, and still have persistent reflux. Others have a mechanical problem that no medication can fix. Those are the patients we cannot simply medicate our way out of. That brings us to the next step: what can we do without immediately returning to a major operation?

Next, we will discuss endoscopy and other options performed through the mouth.

Fixing Reflux Through the Mouth, with No Incisions

So the pills are not enough. But you are not ready for another major operation—and honestly, neither am I, if we can avoid it. Is there anything in between? Yes. We have several tools we can use through the mouth. No incisions. No scars. We pass a scope and work from the inside.

Some of these treatments are genuinely useful. Others do notwork well after a sleeve. You deserve to know the difference. Let’s start with the procedure people often ask about: TIF, or transoral incisionless fundoplication.

TIF uses a special device to create a new valve at the top of the stomach using the stomach’s own fundus. The tissue is folded, secured, and shaped into a valve—without external incisions. The problem after a sleeve is simple: TIF needs the fundus.

The fundus is the soft, upper part of the stomach used to create the wrap. During a sleeve, that tissue is removed. So after a sleeve, a standard TIF usually is not possible. There is simply not enough tissue to work with.

If someone offers you a standard TIF after a sleeve, ask detailed questions about your anatomy and how the procedure would be performed. TIF can work well before a sleeve or in people who have not had bariatric surgery. Some surgeons also combine TIF with endoscopic stomach-tightening procedures. But once the fundus has been removed, that option is largely closed.

So what can we do inside a sleeve?

Mucosal procedures

The first group is called anti-reflux mucosectomy or mucosal ablation. The idea is fairly simple. At the valve area near the top of the stomach, we either remove a small crescent of the lining or treat it with controlled energy. As the area heals, scar tissue forms and tightens the opening—like pulling a drawstring closed.

The results are encouraging. Across studies, these procedures help roughly three out of four patients. One large review reported improvement in about 87% of patients after ablation and about 78% after the cutting technique. Many patients had less acid exposure and were able to reduce or stop their acid medication.

But these procedures carry real risks. Removing or treating the lining can cause bleeding. It can also create a stricture—a narrowing that may require dilation. In one large comparison, the cutting approach had more than ten times the risk of stricture, bleeding, and perforation compared with the gentler radiofrequency approach.

So these treatments can help, but they are not risk-free. They should be performed by someone with specific expertise.

Radiofrequency treatment

Another option is radiofrequency treatment, commonly known by the brand name Stretta. A scope delivers controlled heat energy to the muscle around the lower esophageal valve. The goal is to strengthen the valve and reduce how often it opens. The evidence is mixed.

In people with normal, non-surgical anatomy, Stretta has shown some benefit. About half of patients may be able to stop their acid medication, and symptoms and quality of life can improve. But in higher-quality studies, acid exposure itself has not always improved much. Some of the benefit may come from changing how the esophagus senses acid rather than reducing the amount of reflux.

And after a sleeve, the results have been disappointing. Stretta does not appear to work as reliably in a post-sleeve stomach. So I am cautious about promising much from it in that setting.

Electrical stimulation

You may also read about electrical stimulation of the lower esophageal valve—almost like a pacemaker for the esophagus. Early studies looked promising. The treatment appeared to strengthen the valve and reduce acid exposure. It could even be placed during a hiatal hernia repair.

But the primary company ran into problems, the major trial was stopped, and the treatment is not practically available in most settings today. For now, it is more a treatment of interest than one I can routinely offer.

Treating a twist or stricture

Now let’s look at a completely different cause of reflux—one with a very direct solution. Sometimes the problem is not a weak valve at the top. Sometimes there is a blockage lower down. A sleeve can develop a twist or a narrowing, often near the middle indentation called the incisura. When that happens, food and fluid backup above the narrowing and spill into the esophagus.

Think of it like a kink in a hose. Pressure builds behind the kink. In that situation, the answer is not a valve procedure. The answer is to open the narrowing.

Often, we can do that through the scope with balloon dilation. We start gently. If needed, we repeat the treatment with progressively larger balloons—such as 30, 35, and then 40 millimeters—over several weeks. About three out of four patients improve with dilation alone, usually after one or two sessions.

If dilation keeps failing, the next step may be a stent. The stent holds the narrowed area open while it heals. Only after those approaches fail do we consider another operation.

The sequence is straightforward:

1. Balloon dilation.
2. Stent placement if necessary.
3. Surgery only as a last resort.

Timing matters. During the first six weeks after a sleeve, the staple line is still healing, so I am very cautious about aggressive dilation. The risk of causing a tear is higher. But at the right time, opening a stricture can eliminate the reflux because it treats the actual cause.

So here is the bottom line:

• After a sleeve, standard TIF usually is not possible because the fundus is gone.
• Mucosal tightening procedures can help, but they carry real risks.
• Stretta has been underwhelming after a sleeve.
• Electrical stimulation is not realistically available.
• If reflux is caused by a twist or stricture, endoscopic treatment may provide a genuine solution.

These tools can be an important middle ground. For the right patient, they may provide relief without a major operation. But in many sleeve patients with significant mechanical reflux, they are a bridge rather than a permanent destination. When they are not enough, we move to the definitive options. That is the focus of the next section.

Fixing the Reflux Without Undoing Your Sleeve

Here is a situation many patients recognize. You had a sleeve. You lost weight, and you should be proud of that. But now you have reflux. The medication is not enough, and the endoscopic treatments have not solved the problem.

Then someone mentions a bypass. Your stomach drops. You did not choose a bypass. You do not want the rerouting, the ulcer risk, the lifelong vitamin requirements, or an entirely different operation.

So the question is completely reasonable:

Can we fix the reflux without converting the sleeve to a bypass?

Sometimes, yes. Several procedures are considered anatomy-sparing. They leave the sleeve in place and try to rebuild the anti-reflux barrier at the top. But before we consider any of them, two conditions must be met.

Gate one: Your esophagus must squeeze normally

We need to know that your swallowing muscles work before we tighten the outlet. Every anti-reflux procedure creates more resistance at the bottom of the esophagus. That is the point: the valve must resist reflux. But the esophagus above it must be strong enough to push food through.

If the esophagus is weak or does not relax properly, tightening the outlet can create a new problem. You may have difficulty swallowing. Food may become stuck. In some cases, that problem can be severe or persistent.

That is why we perform manometry before surgery. It measures the strength and coordination of your swallowing muscles. This is not just a formality. In patients who had weak esophageal contractions before receiving a magnetic ring, postoperative swallowing problems and the need for dilation were more common. And in a study of more than 1,000 patients evaluated before anti-reflux surgery, about 3% had an undiagnosed swallowing disorder, including an achalasia-type problem.

If the esophagus does not function properly, we do not proceed with these procedures.

Gate two: There cannot be a significant narrowing in the sleeve

A sleeve can develop a twist or stricture, often near the incisura. That narrowing can cause reflux because food and acid backup above the obstruction. This creates an important trap. If you only look at the top of the stomach, you may think the valve needs to be tightened. But if the real problem is a blockage in the middle, tightening the top can make things worse. It traps more pressure above the narrowing.

You have to open the blockage, not tighten the outlet. Before considering an anatomy-sparing anti-reflux procedure, we need to confirm that the sleeve is open and straight. That usually means evaluating it with endoscopy and a contrast swallow study. If there is a significant twist or stricture, these procedures are the wrong answer. The sleeve may need to be opened, or it may need to be converted to a bypass.

Now, if your esophagus squeezes normally and your sleeve is open and straight, we can discuss the anatomy-sparing options.

Hiatal hernia repair

The simplest option may be to repair a hiatal hernia. Sometimes the upper part of the sleeve has migrated into the chest through the diaphragm. If that is the main problem, we can pull the sleeve back into the abdomen and close the opening in the diaphragm. In some studies, repairing a migrated sleeve reduced reflux in up to 72% of patients, and many were able to stop their acid medication.

The concern is durability. The opening can come back, and the sleeve can migrate again. In some patients, hernia repair alone does not provide a lasting solution. That is why surgeons have developed additional ways to reinforce the repair.

Ligamentum teres cardiopexy

One option is ligamentum teres cardiopexy. The ligamentum teres, also called the round ligament, is a strong band of tissue that runs from the belly button toward the liver. It is well anchored in the abdomen. The surgeon can keep it attached, bring it around the lower esophagus like a sling, and use it to help anchor the top of the sleeve in the abdomen. It creates a valve-like effect.

Early results have been encouraging. In sleeve patients, symptom improvement has been reported in roughly 80% to 86% of cases. The operation is relatively short, hospital stays are generally brief, and one series reported that only about 3% of patients needed another operation. But the long-term evidence is not strong.

An older randomized trial found that many patients needed another anti-reflux operation within a year, and acid exposure remained high. In a more recent series of sleeve patients, reflux returned in about 75% overtime. Expert consensus groups have not broadly endorsed this procedure for sleeve reflux because most of the evidence comes from small studies with limited follow-up.

So my honest view is this: it may be a reasonable option fora carefully selected patient, especially someone who strongly wants to avoid a bypass. But its durability remains uncertain.

The magnetic ring: LINX

Another option is the LINX magnetic ring. It is a small bracelet made of magnetic titanium beads that sits around the lower esophagus. The magnets keep the valve closed against reflux. When you swallow, food pushes the beads apart. Afterward, they comeback together.

In sleeve patients, the early results are encouraging. Studies have shown major improvements in quality of life, and about 80% of patients were able to stop their acid medication. But there are important trade-offs. The device is permanent. It can rarely erode into the esophagus, although that occurs in less than 1% of patients. Some people develop significant difficulty swallowing and may need dilation or removal of the device.

That is why the manometry test—the first gate—is especially important before considering LINX. The device also affects which MRI scans you can have. And we still do not have strong long-term data in sleeve patients, so expert opinion remains divided.

Fundoplication

Now let’s address the classic operation: fundoplication. In patients with normal stomach anatomy, fundoplication is a well-established anti-reflux operation. The surgeon wraps the fundus around the esophagus to create a new valve. But after a sleeve, the fundus is gone. It is the very part of the stomach that was removed.

So a standard fundoplication usually is not an option after a sleeve because there is no longer enough tissue to create the wrap. Fundoplication may be useful when performed at the time of the original sleeve, before the fundus is removed. But as a rescue procedure after the sleeve, it generally is not available.

Putting it together

Before considering an anatomy-sparing operation, two things must be true:

1. Your esophagus must squeeze normally.
2. Your sleeve must be open and free of a significant twist or stricture.

If either condition is not met, these procedures are not appropriate. The treatment may instead involve opening the sleeve or converting it to a bypass. If you pass both tests and want to preserve your sleeve, there are real options.

• A migrated sleeve may improve with hernia repair.
• Ligamentum teres cardiopexy may help selected patients, but its long-term durability is uncertain.
• LINX can improve reflux and allow many patients to keep their sleeve, but it is a permanent implant with important risks and limited long-term data.
• A standard fundoplication is generally not possible because the fundus has been removed.

These procedures can be useful. But none has the same long-term evidence as conversion to a gastric bypass. For reflux that continues despite medication and endoscopic treatment, bypass conversion remains the operation with the strongest evidence. Studies report reflux improvement in roughly 60% to 100% of patients, with more durable results.

That does not make it the only answer. It makes it the option we can support with the most data.

The Operation That Actually Fixes It: Conversion Surgery

We have tried the medications. We have tried endoscopic treatment. We have discussed procedures that preserve the sleeve. For some patients, none of those options is enough. The reflux is severe. It is damaging the esophagus. Or the sleeve never produced the weight loss you needed.

For those patients, one operation consistently stands above the others:

Converting the sleeve to a Roux-en-Y gastric bypass.

This is the gold standard for treating severe reflux after a sleeve. That is not just opinion. It is what the evidence shows. When a refluxing sleeve is converted to a bypass, reflux improves or resolves in roughly 60% to 100% of patients. Most patients also reduce or stop their acid medication. After conversion, about 20% to 40% still need some type of acid treatment.

Why does the bypass work so well? First, we create a small pouch at the top of the stomach. That pouch produces very little acid because most of the acid-producing stomach is no longer in the food stream. Second, the bypass routes bile much farther downstream before it meets the food. Bile that was reaching the sleeve and irritating the esophagus is diverted away.

So the bypass addresses three problems at once:

• Less acid production
• Less bile exposure
• Less pressure in the upper stomach

That combination is what makes it such a powerful reflux operation. Here is another number that matters. In five-year randomized trials, patients with a sleeve were about 11 times more likely to need another operation for severe reflux than patients who had a bypass. In those studies, almost no patients in the bypass group needed revision surgery for reflux.

That is a strong result. But I also want to be honest: no operation works perfectly for every patient. One careful study used objective testing rather than relying only on symptoms. It found clear improvement in about half of patients. That may sound lower than some other reports, but it makes an important point: we need to confirm that reflux is truly the problem before recommending a bypass.

Patients who met modern, objective criteria for reflux were the most likely to improve. The more accurately we identify the cause beforehand, the better we can match the operation to the problem.

Many patients also worry that converting a sleeve to a bypass must be much more dangerous than doing a bypass as the first operation. In a large matched analysis, conversion had similar rates of major complications, leaks, and bleeding compared with primary bypass surgery. In experienced hands, it can be performed safely.

What about the OAGB?

There is another option: converting the sleeve to an OAGB, or one-anastomosis gastric bypass. It uses one connection instead of the two used in a standard Roux-en-Y bypass. It can produce more weight loss and may be somewhat faster and technically simpler. But for reflux, the standard bypass performs better.

In direct comparisons, reflux resolved in about 80% of patients after a Roux-en-Y bypass, compared with about 69% after an OAGB. New reflux was also somewhat more common after the OAGB because bile can still reach the stomach and esophagus through that single connection. So how do we choose? If reflux is the main problem, I generally favor the standard Roux-en-Y bypass. It is the most reliable reflux operation we have.

If weight regain is the main problem and the reflux is mild, an OAGB may be a reasonable option because it tends to produce more weight loss. The operation has to match the reason you are having revision surgery.

If the OAGB is causing reflux

Sometimes the OAGB itself causes reflux. When that happens, the treatment depends on what kind of reflux you have. You cannot determine that reliably from symptoms alone. We need objective testing, including pH and impedance monitoring.

If the problem is pure bile reflux, we may be able to divert the bile farther downstream without rebuilding the entire pouch. The pouch stays, but the bile is redirected away from the esophagus. If the problem is acid reflux, or a mixture of acid and bile, bile diversion alone may not be enough. In that situation, the pouch may need to be revised and converted to a standard Roux-en-Y bypass.

When surgeons test first and match the operation to the type of reflux, outcomes are much better. When they guess, reflux is more likely to persist.

Test first. Then choose the operation.

What about the SADI or duodenal switch?

The SADI and the full duodenal switch are excellent procedures, but they are designed primarily for weight loss and metabolic disease—not for treating reflux. These operations keep the sleeve and add a powerful intestinal bypass below it. They are among the most effective procedures for weight loss and diabetes. If weight loss is the main goal, the SADI can be an excellent option.

But the sleeve remains. And the sleeve is still a narrow, high-pressure stomach. That is the problem when reflux is the main concern. The duodenal switch can improve the sleeve’s shape and divert bile lower in the intestine, but it does not remove the high-pressure, acid-producing sleeve. So it does not treat reflux as reliably as a Roux-en-Y bypass.

In one Mayo Clinic series involving the full duodenal switch, reflux resolved in about 45% of patients, while almost 19% developed new reflux afterward. That places the procedure somewhere between a sleeve and a bypass—but much closer to the sleeve than the bypass in terms of reflux control.

The SADI may have lower rates of new or worsening reflux in some comparisons, but it still does not match the standard bypass because the sleeve remains in place.

So this is how I explain it:

• If your main problem is weight, the SADI and duodenal switch are powerful options.
• If your main problem is reflux, they are usually not the best answer because they leave the reflux-prone sleeve in place.
• If you have substantial weight to lose and only mild reflux, one of these procedures might be considered—but only after careful testing and discussion.

What about a re-sleeve?

A re-sleeve means restapling a stretched sleeve to make it smaller and tighter. For reflux, that is usually the wrong operation. There are two main reasons.

First is safety. In the largest database, the leak rate after re-sleeve was about 1.3%. That was roughly 13 times higher than the leak rate after a first-time sleeve and more than twice the rate reported for conversion to a bypass. Re-sleeving was also associated with more readmissions and reoperations.

Second is effectiveness. Re-sleeve performs poorly for additional weight loss compared with the SADI, duodenal switch, OAGB, and bypass. And for reflux, it recreates the same high-pressure tube that caused the problem in the first place. So for a patient whose main issue is reflux, re-sleeve is not a good choice.

Putting the decision together

The decision usually follows a stepwise process. First, we try appropriate medical treatment. If the reflux continues despite treatment and testing confirms significant, refractory reflux, we look at your weight, anatomy, and overall health.

If your BMI is above 35, conversion to a Roux-en-Y bypass is often the clearest option. It can treat the reflux while also addressing persistent obesity or weight regain. If a hiatal hernia is present, we repair it during the same operation.

If your BMI is lower, the discussion becomes more individualized. A bypass may still be appropriate, particularly if you have diabetes or another metabolic condition. But an anatomy-sparing procedure, such as a magnetic ring in selected patients, may also be reasonable. In a leaner patient, we have to weigh the benefits of bypass against the potential for nutritional problems and the need for lifelong monitoring.

No matter which procedure is being considered, a second operation requires a full evaluation again:

• Nutrition assessment
• Psychological assessment
• Endoscopy and imaging when indicated
• Reflux and motility testing
• Review of medications, weight history, and medical conditions

Revision surgery is more complex than the original operation. The goal is to choose carefully, do it once, and do it correctly.

The bottom line is this:

For severe reflux after a sleeve, conversion to a Roux-en-Y gastric bypass has the strongest evidence, the highest likelihood of lasting improvement, and the most reliable long-term results. An OAGB may be reasonable when weight loss is also a major goal, but it is generally less reliable for reflux. The SADI and duodenal switch are powerful weight-loss operations, but they leave the sleeve in place and are not primarily reflux procedures.

And a re-sleeve rebuilds the high-pressure anatomy that caused the reflux, so it is generally the wrong choice for this problem. Match the operation to the reason you are having revision surgery—and confirm the diagnosis before you commit.

Which Fix Actually Lasts: Durability and Reoperation

By now, you’ve heard about the options:

Convert to a bypass. Wrap the ligament. Place a magnetic ring.

And a fair question is probably forming in your mind:

Which one actually lasts?

Here is what many people are not told: almost every option looks good at one year. At twelve months, the ligament wrap may look successful. The ring may look successful. The bypass may look successful.

But the real test is not one year. The real test is five years. Ten years. Does the repair hold, or does the reflux slowly return?

Let’s look at each option honestly, including how each one can fail. Every operation has a failure pattern, and you deserve to understand all of them.

Bypass conversion

Let’s start with the bypass conversion—the gold standard. It has the deepest and longest track record by far. In five-year randomized trials, patients who stayed with a sleeve were about eleven times more likely to need another reflux operation than patients who underwent bypass. In the bypass group, essentially no one needed a repeat reflux operation in those trials.

In several studies, patients were still off their acid medication years later. Their reflux had not simply improved. It had stayed gone. That is why bypass is considered durable.

But bypass has its own risks, and I will not hide them from you. It can cause an ulcer where the pouch meets the intestine, especially if you smoke or take anti-inflammatory medications. It can cause an internal hernia or a bowel kink later on. It can also cause dumping syndrome.

And a small number of patients still have some reflux after a technically successful bypass. When bypass patients need another operation, it is usually because of one of those problems—an ulcer, hernia, narrowing, or another mechanical issue. It is usually not because the reflux repair itself suddenly failed. The reflux treatment is highly reliable. The later operations are generally for other parts of the bypass anatomy.

Ligament wrap, or cardiopexy

Now let’s talk about the ligament wrap, also called a cardiopexy. This is where I need to be especially careful, because the early results can look very appealing. At one year, about 80% of patients have improved. The 30-day reoperation rate is low—around 3%. The average hospital stay is about a day and a half.

On paper, that looks excellent. But the longer-term picture is less certain. The procedure uses a soft band of tissue to recreate or reinforce the valve at the top of the stomach. Soft tissue can stretch. The repair can loosen. And the hiatal hernia underneath can return.

In longer-term reports, reflux came back in a substantial proportion of patients. In one sleeve series, the recurrence rate was as high as three out of four patients. Some eventually needed conversion to a bypass, sometimes only a year or two later. That means they underwent two operations to reach a result that one operation might have provided.

This is why expert consensus groups have not endorsed the ligament wrap as a proven, durable solution. That does not mean it never works. It means we cannot yet promise that it will still be working five years from now. I therefore reserve it for a specific patient: someone who firmly refuses a bypass, understands that the long-term durability is unproven, and accepts that the procedure may buy time rather than solve the problem permanently.

Magnetic ring

Now let’s discuss the magnetic ring. This option is interesting because we have long-term data extending beyond five years—at least in patients with reflux who have not undergone bariatric surgery. That data is reassuring in terms of effectiveness. At more than five years, about 80% of patients still reported major improvement in reflux-related quality of life. About 90% were no longer taking daily acid medication.

So when the ring remains in place and continues to function, it can keep working. But that phrase—when it remains in place—is important. The ring’s main failure mode is the device itself. In one long-term study, about 13% of patients eventually had the device removed. Reasons included ongoing difficulty swallowing, reflux that did not improve, or, rarely, erosion of the device into the esophagus.

Erosion is uncommon—around 1% to 2%—and it can usually be managed safely. But it is real, and it is one of the complications we monitor most closely. The ring can also fail in the same way other reflux repairs fail. If the hiatal hernia comes back, the device may move with it.

And there are practical limitations. The ring is a permanent implant, and it affects which MRI scans you can safely undergo. There is another important issue for sleeve patients: our long-term data on the ring in this population is limited. In sleeve series, device removal for erosion was under 1%,which is encouraging. But those studies involved small numbers of patients and shorter follow-up.

So we are borrowing some confidence from patients who never had bariatric surgery and applying it to sleeve patients. That may prove reasonable. But hope is not the same as proof.

Comparing the options

Let me put the three options side by side, plainly—as I would if you were sitting across from me. If you want the most durable and best-proven reflux solution, with five-year randomized data showing that reflux remains controlled, that is the bypass conversion. It has important risks of its own, including ulcers, internal hernias, and dumping syndrome. But the reflux treatment itself is the most reliable option we currently have.

If you want to keep your sleeve and avoid a bypass, the ligament wrap and magnetic ring can provide alternatives. The ring has stronger long-term effectiveness data, but most of that evidence comes from patients who did not have bariatric surgery. Its failure mode involves the device itself, including swallowing problems, erosion, or removal—about one patient in eight over the long term in the available study.

The ligament wrap is less invasive and may involve an easier recovery. But it has the weakest durability data, with a clear concern that reflux may return over time. And this is exactly why the diagnostic workup matters. The durability of any treatment depends on identifying the true problem first.

If we tighten the top of the stomach when the real problem is a twist in the middle of the sleeve, the repair is unlikely to last. If we add resistance in front of a weak esophagus, you may not be able to swallow properly.

Before choosing a procedure, we need to confirm the cause of the reflux. We need to confirm that the esophagus can move food downward. And we need to confirm that the sleeve is open and not twisted or narrowed. Only then can we know whether the durability data applies to you.

The bottom line

There is a trade-off between preserving your existing anatomy and choosing the option with the strongest long-term certainty. The bypass changes your sleeve anatomy, but it offers the most durable and best-proven reflux treatment. The wrap and the ring allow you to keep the sleeve, but you accept less long-term evidence—and the possibility that a repair can loosen or that a device can cause problems or require removal. There is no risk-free option.

There is only the option that best matches your anatomy, your priorities, and your willingness to accept uncertainty. The goal is to make that choice with your eyes open.

The Part You Cannot Feel: Surveillance After Surgery

I want to spend a few minutes on something that could save your life. I mean that literally. Here is the hard truth about reflux after a sleeve: much of the damage happens silently. You may not feel it.

Earlier, I explained that many patients with real acid damage in the esophagus have no heartburn at all. That cuts both ways. You cannot use symptoms as your smoke detector. Feeling fine does not necessarily mean everything is fine.

That is why we do not wait for symptoms. We look on a schedule, whether you feel anything or not.

The tool is an upper endoscopy—the same scope we have discussed throughout this series. We gently pass a camera down to examine your esophagus, your sleeve or pouch, and the connection between them. We can take biopsies when needed. The procedure takes only a few minutes. You are sedated, and you usually go home the same day.

So what are we looking for? One important condition is called Barrett’s esophagus. When acid repeatedly damages the lining of the esophagus, that lining can change. It tries to protect itself by transforming into a different type of tissue. That tissue carries a risk. Over many years, in a small number of people, it can progress to esophageal cancer.

Barrett’s is a warning sign. It is a step that can come before cancer. This matters especially after a sleeve. In the general population, Barrett’s affects roughly one in two hundred people. After a sleeve, long-term studies report rates ranging from about 4% to 18%, depending on the study and the length of follow-up. Even the more conservative estimates show a substantial increase over baseline.

That is not a reason to panic. It is a reason to look. The good news is that when Barrett’s is found early, we can act. We can monitor it closely. We can treat it before it becomes cancer. In some cases, converting to a gastric bypass can help control the acid exposure.

Caught early, this is a manageable problem. Caught late, it can become much more serious. The difference is whether we find it in time. Now let’s talk about the surveillance schedule. I want to be honest: expert groups do not all recommend exactly the same timing.

The main international bariatric society, IFSO, recommends an endoscopy one year after sleeve or one-anastomosis gastric bypass surgery, followed by repeat examinations every two to three years.

Other groups use a different schedule. You may hear one year, then three years, then five years. The American bariatric society recommends an endoscopy by three years after surgery if you have not had symptoms, followed by examinations every five years if the first study is normal. The French society recommends examinations at one, three, five, and ten years.

The exact numbers differ. But the central message is consistent:

You need routine endoscopies even when you feel completely well. That is the part I want you to remember. If we find Barrett’s, the schedule becomes more frequent. We monitor you at shorter intervals and take careful biopsies according to cancer-surveillance guidelines.

That is not a failure. It means the system is working. We found the problem while it was still manageable. Now, a special word for patients with a one-anastomosis gastric bypass.

With this operation, we monitor two additional issues. The first is bile. Because of the way the intestines are connected, bile can move back into the pouch. Over time, that can irritate the lining. Five-year studies show that pouch inflammation may increase gradually, particularly after the fourth year and especially in smokers and heavy drinkers.

The second issue is ulcers at the connection. This operation may carry a somewhat higher risk of those ulcers. And here is the important point: how you feel may not match what the scope shows. Patients can feel perfectly well while the endoscopy shows significant inflammation. So symptoms are not enough for one-anastomosis bypass patients either.

We may recommend endoscopies at one, three, and five years, with biopsies when appropriate—even when you feel great. The pouch and its connection are areas we can evaluate properly only by looking directly. Let me bring this together. Surgery is not the finish line. It is the beginning of long-term care. Part of that care means keeping up with your endoscopies, including during the years when you feel wonderful.

In fact, those may be the most important years to keep your appointments, because the damage that matters most may be the damage you cannot feel. So know which operation you had. Know your surveillance schedule. Put your endoscopy on the calendar, just as you do your blood tests and follow-up visits.

If years have passed and no one has examined you since surgery, do not feel guilty. Use that as a reason to call your surgical or gastroenterology team today. You already did the hard part. You changed your life.

Now protect that change. Keep your follow-up appointments, get checked, and find the small problems while they are still small.

What the Experts Actually Agree on, and Where They Don’t

I’ve given you a lot of my own perspective in this video. So now I want to step back and show you where the major expert groups stand. These recommendations are not one surgeon’s opinion. They come from specialists who reviewed the evidence, debated the options, and reached formal conclusions.

Let’s start with the American Society for Metabolic and Bariatric Surgery—the ASMBS. Their guidance on revision surgery after a sleeve matches what I’ve told you. Start with medication. If medication fails, conversion to a gastric bypass is the most effective treatment we have for reflux.

Their reported reflux-resolution rate is about 60% to 100%.Most patients can also stop acid-suppressing medication, although roughly 20%to 40% may still need it. The ASMBS also recognizes other options. A hiatal hernia should be repaired when it is contributing to the reflux or when the sleeve has moved into the chest. A magnetic ring may be considered for selected patients who cannot or will not undergo a bypass.

But the bypass remains the anchor. Now let’s look at the Society of American Gastrointestinal and Endoscopic Surgeons—the SAGES. They framed the decision in a practical way. Most patients should try medical treatment first. The harder question is what to do when medication no longer controls the reflux.

Their recommendations take your body weight into account. If your reflux is medically refractory—meaning medication is no longer controlling it—and your BMI is above 35, they recommend conversion toa gastric bypass. That can address both problems: the reflux and the excess weight. If you have a hiatal hernia, they recommend repairing it at the same time.

If your BMI is between 30 and 35, both a magnetic ring and a bypass may be reasonable options. But if you also have diabetes or another metabolic condition, they lean toward the bypass because it may provide additional metabolic benefits.

They also make a specific point about patients of Asian descent in this BMI range. Because metabolic disease can develop at a lower body weight, a bypass may be more beneficial for some of these patients as well. If your BMI is below 30, both the ring and the bypass can still be considered. But a bypass in a thinner patient requires a serious discussion about long-term nutritional risk.

And if a hiatal hernia is the main problem, repairing the hernia alone may be enough in the right patient. Now let’s turn to the American College of Gastroenterology—the ACG. These are the medical reflux specialists. Their recommendations begin with the basics, and those basics matter.

Lose weight if you are overweight. Weight loss can genuinely improve reflux. Avoid eating right before bed. Stop smoking. And take your acid medication correctly—usually 30 to 60 minutes before a meal, not at bedtime.

The ACG also addresses severe esophagitis. If you have grade C or grade D esophagitis, you should not simply stop treatment when you feel better. You generally need long-term medication or an operation. They also recognize gastric bypass as a reflux treatment for appropriate patients with obesity, and they recognize the magnetic ring as an alternative to a traditional anti-reflux wrap.

Now, the International Federation for the Surgery of Obesity and Metabolic Disorders—the IFSO. You heard about their surveillance recommendations earlier: an endoscopy at one year after a sleeve or one-anastomosis bypass, followed by repeat scopes every two to three years. But IFSO also highlights an important gap between guidelines and real-world practice. When bariatric surgeons were surveyed, most knew about the surveillance recommendations. But many were not routinely performing those follow-up endoscopies.

So the guideline says, “Look.” And in many places, patients are still not being looked at regularly. That is why you have to advocate for yourself. If your surgeon does not bring up surveillance, ask about it.

And now we come to the international consensus that brings many of these issues together. In 2023 and 2024, experts from 25 countries took part in a formal Delphi consensus process. In this process, experts vote anonymously over multiple rounds until the group identifies where genuine agreement exists. There were 46 experts and 72 statements. Their recommendations were organized partly around what happened to the patient’s weight after the sleeve.

Here is what they agreed on. If you have reflux after a sleeve and achieved good weight loss, they supported two main options: medical treatment, which may be continued for at least one to two years, or conversion to a gastric bypass. More than 97% supported the bypass. If you have reflux and did not lose enough weight—or if you regained weight—the recommendation was again conversion to a bypass, with more than 97% agreement.

And if you lost too much weight, the bypass was still the preferred option, with 98% agreement. So regardless of whether you lost the expected amount of weight, too little, or too much, the bypass was the operation the experts repeatedly returned to. That is a remarkable level of agreement. But I also want you to hear where agreement did not exist.

The panel did not support most of the sleeve-sparing procedures as standard solutions for reflux. That includes the ligament wrap, stand-alone hernia repair, modified Hill repairs, right-crus gastropexy, OAGB, duodenal switch, and SADI. That does not mean these procedures never help anyone.

It means the evidence is still based mainly on small studies, short follow-up, or case reports. The data is not strong enough to make them the default treatment for a patient whose esophagus is at risk. There was one procedure the experts could not settle: the magnetic ring. They did not reach consensus either for or against it.

So when I tell you that the ring may be reasonable for carefully selected patients, but that the long-term evidence is still unsettled, I am not avoiding the question. I am describing the actual state of the field. Let’s bring this together.

Across the surgical societies, the gastroenterology experts, the international bariatric federation, and the worldwide consensus panel, the message is remarkably consistent:

• Start with appropriate medical treatment.
• If medication fails, gastric bypass has the deepest evidence and the broadest support.
• Repair a hiatal hernia when it is part of the problem.
• Use your BMI, weight-loss history, and metabolic conditions to guide the decision.
• Treat sleeve-sparing procedures as selective options—not proven replacements for bypass.

The wraps and rings may have a role for carefully chosen patients who understand the limitations. But the wrap remains weakly supported by long-term evidence, and the ring remains controversial. That is not simply one surgeon’s preference. It is where the field currently stands.

And when experts across different specialties agree this strongly, it is worth listening.

What We Still Don’t Know, and Why That Matters to You

We’ve reached the end. And I want to close by doing something many doctors are uncomfortable doing on camera. I want to tell you what we still don’t know.

You’ve heard me speak confidently about several things:

Convert a sleeve to a bypass when appropriate. Watch for Barrett’s esophagus. Have surveillance endoscopies, even when you feel fine. All of that is supported by real evidence.

But if I stopped there, I would be giving you a version of the story that is cleaner than reality. You deserve the full truth. The first major gap is the one that bothers me most. We have never performed the study that would settle the treatment debate.

Throughout this series, I’ve compared three options: gastric bypass, ligamentum teres cardiopexy, and the magnetic ring. I’ve shown you the results reported for each one. But those results come from different studies, involving different patients, in different centers, using different definitions and measurements.

No one has taken a large group of patients with reflux after sleeve surgery, randomly assigned them to bypass, a ligament wrap, or a magnetic ring, and followed them all for many years. That study does not exist. So when I tell you that bypass is the most proven option, that is absolutely true.

But “most proven” does not mean it won a perfectly fair, head-to-head competition. We’re comparing one horse that ran on Monday with another that ran on Wednesday. Until these operations are studied in the same patients, on the same track, some uncertainty remains. And you should know that.

The second gap sounds less exciting, but it affects almost everything. We still cannot agree on exactly what counts as reflux.

I’m serious. You’ve heard that reported reflux rates can range from below10 percent to more than 50 percent after the same operation. Now you know why. One study defines reflux as heartburn. Another requires inflammation seen during endoscopy. Another counts only a positive acid study.

They use the same word for different conditions. Trying to compare those studies is like adding measurements when some are in inches and others are in centimeters—and no one tells you which is which.

Experts have described what a better study should include:

• A validated symptom questionnaire before and after surgery.
• Clear documentation of who is taking reflux medication, and why.
• At least one year of follow-up—ideally much longer.
• Objective testing, including endoscopy and reflux monitoring, rather than symptoms alone.

We know what high-quality evidence should look like. The problem is that the field does not apply those standards consistently yet. Until it does, every number you hear should carry a small asterisk. The third gap is more hopeful, because progress is happening.

We’re getting better at predicting who is likely to develop reflux. But we have not yet turned that prediction into a tool we can fully trust when making an individual treatment decision.

You may remember the risk factors we discussed:

Your BMI.

Diabetes.

Triglycerides. A hiatal hernia.

Existing reflux. The shape of your angle of His. The condition of your anti-reflux valve. Some prediction models are genuinely impressive on paper. One recent multicenter model showed strong accuracy when identifying patients at risk for reflux.

That is real progress. Ten years ago, we were relying much more on clinical judgment and educated guesses. But there is an important limitation. A model can perform well in a database and still fail to prove that it improves care in real life.

No one has yet taken one of these risk scores, used it prospectively to guide patients toward a bypass or a sleeve, and then shown that this approach actually reduces reflux years later. That is the study we still need. Use the calculator. Make the surgical decision. Then prove that the decision leads to better lives.

We’re close to that kind of evidence. But we’re not there yet. So what does all of this mean for you? I don’t want you to hear, “We don’t know everything,” and conclude that treatment is just a coin toss.

That would be the wrong lesson. Here is the right lesson. Some things are firmly established. Sleeve surgery causes more reflux than gastric bypass. That is not seriously in doubt.

Long-term data shows a clear difference between the two operations. In patients with confirmed reflux, the burden after sleeve surgery can be far higher than after bypass. Gastric bypass remains the most reliable treatment we have for reflux after a sleeve. That is also well supported.

And much of the dangerous damage from reflux can occur silently. You cannot rely on symptoms alone. Surveillance endoscopy matters. Those are the solid pillars. Build your decisions on them.

The unsettled questions involve the finer choices:

• A ligament wrap versus a magnetic ring for someone who does not want a bypass.
• The ideal endoscopy schedule.
• Which risk calculator should guide surgical planning.
• How long newer procedures will continue to work.

Those are real debates. Thoughtful surgeons may reach different conclusions. That does not mean your care is weak. It means you are standing at the honest edge of the science—and that edge is moving.

So what do you do with an imperfect map? You use the parts that are well established. You respect the areas marked “unknown.” And you travel with someone who knows the territory.

Find a surgeon who treats this problem regularly. Choose someone who investigates the real cause before operating, rather than discovering it afterward. Someone who confirms that your esophagus works properly and that your sleeve is open and not twisted before offering an anatomy-sparing procedure. Someone who recommends surveillance endoscopy on an appropriate schedule, even when you feel completely well.

And someone honest enough to tell you which parts of the plan are proven—and which parts reflect their best judgment. That surgeon will not have every answer. No one does. But they will understand the difference between what is established and what is still being tested.

And they will tell you the truth about both. Over a lifetime, that may protect you more than any single operation. You’ve given me a great deal of your time throughout this series. Thank you for that.

Take care of yourself. Get evaluated. Ask difficult questions. And never let anyone tell you that reflux is simply something you have to live with.

Now you know it isn’t.

Real science.

Real surgery.

Real results.